Drugs / LiveSpo DIA30
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05812820 | Jul 2022 → Dec 2023 | diarrheal disease | National Children's Hospital, Vietnam | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LiveSpo DIA 30 | “the efficacy of two types of probiotics, the first one containing 2 billion B. clausii spores (LiveSpo® CLAUSY) per ampoule, and the second one containing 5 billion spores of...” NCT05812820 ↗ |
| Modality | Other / unclassified | “high-dose multi-strain Bacillus spore probiotics (LiveSpo DIA30)” PMID 40826150 ↗ Aug 2025 |